menu

COVID-19
webinar series

Download the slides from the past webinars in this series, or watch them on-demand

Webinar 1

COVID-19 Serology Assays: To test or not to test?

View Webinar On-Demand | Download Slides

Over the last 6 months, we have all been severely impacted by the COVID-19 pandemic around the world. An unprecedented global effort has taken place to contain and hopefully reduce the impact of COVID-19 on everyone’s lives. Healthcare professionals have been at the frontline of this initiative with the support of public and private sectors. Academic, biopharmaceutical and diagnostic research has increased our knowledge of the SARS-CoV-2 virus and the physiopathology of the COVID-19 infection. In response, Public Health and Regulatory Authorities, policy makers and governments are rapidly adapting to mitigate the risk of COVID-19 spread in the population. In this context, In Vitro Diagnostic (IVD) device manufacturers have quickly produced serology tests detecting the presence of antibodies to SARS-COV-2 virus. Utilizing such tests as the ultimate sentinel to make decisions to cope with and react to the COVID-19 pandemic is being considered. But can it be that simple?

Agenda:
  •  Overview of the immune response to COVID-19 infection
  •  Diagnostic testing concepts
  •  Serology tests to estimate COVID-19 exposure in the general population
  •  How Serology tests can be the basis of “Certificate of Immunity”
  •  Serology tests and laboratory solutions to support clinical trials

 Speaker:
  •  Patrice Hugo, Ph.D., Immunology, Chief Scientific Officer

 
View Webinar On-Demand | Download Slides

 
Webinar 2

Laboratory Solutions to Support Global COVID-19 Clinical Trials 

View Webinar On-Demand

The COVID-19 pandemic has impacted laboratory testing in global clinical trials of both COVID-19 and non-COVID-19 treatments. This webinar examines laboratory testing and operational considerations required in the time of COVID-19, and specifically for clinical trials studying COVID-19 treatments. To what degree will process changes remain after the pandemic subsides?

Gain insight into COVID-19 test development, and how genomics, flow cytometry, immunoassay, and bioanalysis can support COVID-19 studies. Our subject matter experts will discuss business continuity measures, such as temperature monitoring and lab space redesigns, and adaptations in robust specimen collection kit ordering and tracking, as well as sample tracking, which have increased in complexity from inter-country flight restrictions. Learn about the implications of recent surges in demand for home specimen collection and local lab data management.

Agenda:
  •  Clinical trial testing approaches for COVID-19 and non-COVID-19 studies in the time of COVID-19
  •  The impact of COVID-19 on global clinical trial laboratory testing and operations
  •  Patient centricity in the time of COVID-19

Speakers:
  •  Tony Brown, Vice President and General Manager, Global Central Labs
  •  Patrice Hugo, Ph.D., Immunology, Chief Scientific Officer
  •  Caroline Keane, Senior Vice President, Project Services

 
View Webinar On-Demand